Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer

Annals of Surgery

Volumn 229, Issue 2, 1999, Pages 286-291

  Gupta, Naresh C ^a,b   Graeber, Geoffrey M ^a   Rogers II, John S ^a   Bishop, Harry A ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; HISTOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033498194     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199902000-00018     Document Type: Article

References (14)

1. Webb RW, Gatsonis C, Zehrhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991; 178:705-713.
2. Staples CA, Muller NT, Miller RR, Evans KG, Nelems B. Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy. Radiology 1988; 167:367-372.
3. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182:319-323.
4. Gambhir SS, Hoh CK, Phelps ME, Madar I, Maddahi J. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. J Nucl Med 1996; 37:1428-1436.
5. Gupta NC, Frank AR, Dewan N, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1992; 184:441-444.
6. Gupta NC, Dewan N, Maloof J, et al. Superiority of FDG PET imaging in predicting the probability for malignancy in patients with indeterminate solitary pulmonary nodules. Radiology 1994; 193:131P.
7. Dewan ND, Gupta NC, Redepenning LS, Phalen JJ, Frick MP. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Chest 1993; 104:997-1002.
8. 18F]fluorodeoxyglucose PET. J Nucl Med 1992; 34:21P.
9. Steinert HC, Hauser M, Allenman F, et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997; 202:441-446.
10. Valk PE, Pounds TR, Hopkins DM, et al. Staging non-small cell lung cancer by whole body positron emission tomographic imaging. Ann Thorac Surg 1995; 60:1573-1582.
11. Wahl RL, Quint LE, Greenbough RL, et al. Staging of mediastinal non-small-cell lung cancer with FDG PET, CT and fusion images: preliminary prospective evaluation. Radiology 1994; 191:371-377.
12. Nolop KB, Rhodes CG, Brudin LH, et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 1987; 60:2682-2689.
13. Lowe VJ, Hoffman JM, DeLong DM, Patz EF, Coleman RE. Semi-quantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994; 35:1771-1776.
14. Gallagher BM, Fowler JS, Gutterson NI, et al. Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of F-18-2-deoxy-2-fluoro-D-glucose. J Nucl Med 1978; 19:1154-1161.